Speaker illustration

Doctor Prathap Kanagala

Liverpool University Hospitals NHS Trust, Liverpool (United Kingdom of Great Britain & Northern Ireland)

Member of:

European Society of Cardiology
Heart Failure Association

Dr Kanagala (MBBS, MRCP, PhD, FESC, FHFA) is a Honorary Clinical Associate Professor (University of Liverpool) and Consultant Cardiologist at Liverpool University Hospitals NHS Trust. His primary interests are in heart failure and cardiac imaging. He obtained his PhD from the University of Leicester for his work related to characterising HFpEF with cardiac MRI. His awards to date include: University PhD prize; Young Investigator Award (Runner-up) at the British Society for Heart Failure (2015) and Early Career Award (Clinical) Finalist at the Society for Cardiovascular Magnetic Resonance (2018). He has previously held positions in both the Communications and Education Committees of the British Society of Echocardiography delivering multiple National Guideline protocols as either lead or co-author and has published extensively in the fields of heart failure, cardiac MRI and biomarkers. He is currently involved in numerous multi-centre trials, primarily as Principal Investigator.

Microvascular dysfunction in heart failure with preserved ejection fraction: prevalence and prognostic implications

Event: Heart Failure 2021 Online Congress

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Session: Chronic Heart Failure - Pathophysiology and Mechanisms 2

Thumbnail

Prevalence of microvascular dysfunction and association with clinical outcomes in heart failure with preserved ejection fraction

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Stress Cardiac Magnetic Resonance (CMR)

Session: Latest Advances in Cardiac Magnetic Resonance

Thumbnail

Plasma Tenascin-C: a novel prognostic biomarker in heart failure with preserved ejection fraction

Event: Heart Failure 2019 - 6th World Congress on Acute Heart Failure

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Session: Rapid Fire 2 - Biomarker: present and future

Thumbnail

Characterizing heart failure with preserved and reduced ejection fraction: an integrated clinical, imaging and plasma biomarker approach

Event: Heart Failure 2019 - 6th World Congress on Acute Heart Failure

Topic: Pathophysiology

Session: Chronic Heart Failure – Pathophysiology and Mechanisms

Thumbnail

Relation of focal and diffuse fibrosis assessed by cardiovascular magnetic resonance imaging to clinical outcome in heart failure with preserved ejection fraction

Event: ESC CONGRESS 2017

Topic: Pathophysiology and diagnosis

Session: Chronic heart failure (CHF)

Thumbnail

Prevalence and prognostic significance of right ventricular dysfunction in heart failure with preserved ejection fraction

Event: ESC CONGRESS 2017

Topic: Prognosis

Session: Chronic heart failure (CHF)

Thumbnail

Left atrial ejection fraction: a novel diagnostic and prognostic biomarker in heart failure with preserved ejection fraction, irrespective of cardiac rhythm

Event: ESC CONGRESS 2017

Topic: Pathophysiology and diagnosis

Session: Chronic heart failure (CHF)

Thumbnail

Utility of cardiovascular magnetic resonance imaging in heart failure with preserved ejection fraction for diagnostic and prognostic evaluation

Event: HEART FAILURE 2016

Topic: HFpEF - Heart failure with preserved ejection fraction

Session: Rapid Fire 2 - Imaging in chronic heart failure

Thumbnail

This platform is supported by

logo Novo Nordisk